Explore the prognostic significance of MYC copy number gain detected by FISH analysis in large B-cell lymphoma through this informative conference talk from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delve into Madina Sukhanova's presentation, which examines the impact of MYC alterations on patient outcomes. Gain insights into the latest research on clinical cancer genomics and its implications for accurate diagnosis and targeted therapy selection. Learn about the CGC's mission to promote best practices in cancer genomic testing and their goal of improving patient care through precise genomic profiling. Discover how joining the CGC can provide access to a wealth of educational resources and cutting-edge presentations in the field of cancer genomics.